Results 11 to 20 of about 624,087 (315)

Sero-Surveillance to assess immunity to rubella and assessment of immunogenicity and safety of a single dose of rubella vaccine in school girls

Indian Journal of Community Medicine, 2010
Background: Rubella vaccination is not yet included in National Immunization Schedule in India. Serosurvey is frequently used to assess epidemiologic pattern of Rubella in a community.
Sharma Hitt, Chowdhari Sunil, Raina Tilak, Bhardwaj Subodh, Namjoshi Gajanan, Parekh Sameer   +5 more
doaj   +2 more sources

Dynamics of the Antibody Response After a Third Dose of Measles-Mumps-Rubella Vaccine Indicate a Slower Decline Compared With a Second Dose

Open Forum Infectious Diseases, 2020
Background Breakthrough infections of measles and mumps have raised concerns about the duration of vaccine-induced immunity, which might be improved by a third dose of measles-mumps-rubella vaccine (MMR3).
P. Kaaijk, M. A. Nicolaie, D. V. van Rooijen, M. V. van Houten, F. R. van der Klis, A. Buisman, R. van Binnendijk   +6 more
semanticscholar   +1 more source

Homologous protein domains in SARS-CoV-2 and measles, mumps and rubella viruses: preliminary evidence that MMR vaccine might provide protection against COVID-19

medRxiv, 2020
The COVID-19 disease is one of worst pandemics to sweep the globe in recent times. It is noteworthy that the disease has its greatest impact on the elderly.
R. Franklin, A. Young, Bjoern Neumann, Rocío Fernández, A. Joannides, A. Reyahi, Y. Modis   +6 more
semanticscholar   +1 more source

Changes in the Epidemiology of Rubella: The Influence of Vaccine-Introducing Methods and COVID-19

Vaccines, 2023
Rubella is an infectious disease caused by the rubella virus. Congenital rubella syndrome is a risk for all newborns if pregnant women are infected with rubella, raising an important public health issue.
Naruhito Otani, Masayuki Shima, Takashi Ueda, Kazuhiko Nakajima, Yoshio Takesue, Takuma Yamamoto, Toshiomi Okuno   +6 more
doaj   +1 more source

Vaccine-associated Rubella – a report of two cases and a review of the literature

Human Vaccines & Immunotherapeutics, 2021
We report the clinical characteristics of two adult patients, presenting with a typical erythematous rash consistent with rubella disease after MMR vaccination. Both patients had an uncomplicated clinical course and recovered uneventfully.
Sean Wei Xiang Ong, Shawn Vasoo, Sapna P. Sadarangani, Lin Cui, Kalisvar Marimuthu, Poh Lian Lim, Jing Wen Kong, Judith Chui Ching Wong, Kim Yoong Puong, Kwai Peng Chan   +9 more
doaj   +1 more source

The Concordance between Mumps and Rubella Sero-Positivity among the Israeli Population in 2015

Vaccines, 2022
Mumps and rubella are vaccine-preventable viral diseases through the measles-mumps-rubella-varicella (MMRV) vaccine, administered at 12 months and again at 6 years.
Ravit Bassal, Tamy Shohat, Tal Levin, Rakefet Pando, Eilat Shinar, Doron Amichay, Mira Barak, Anat Ben-Dor, Adina Bar-Haim, Ella Mendelson, Dani Cohen, Lital Keinan-Boker, Victoria Indenbaum   +12 more
doaj   +1 more source

Sero-epidemiology of rubella in the urban population of Addis Ababa Ethiopia [PDF]

, 2000
We conducted a community-based cluster sample survey of rubella sero-epidemiology in Addis Ababa, Ethiopia in 1994. Among 4666 individuals for whom complete data were available, rubella antibody prevalence was 91% (95% confidence interval: 90, 92).
Abebe, A., Cutts, Felicity, Dejene, A., Enquselassie, F., Messele, T., Nigatu, Wondatir, Nokes, D. James   +6 more
core   +2 more sources

Co-evolution of Vaccination Behavior and Perceived Vaccination Risk can lead to a Stag-Hunt like Game [PDF]

, 2022
Voluntary vaccination is effective to prevent infectious diseases from spreading. Both vaccination behavior and cognition of the vaccination risk play important roles in individual vaccination decision making. However, it is not clear how the co-evolution of the two shapes the population-wide vaccination behavior.
arxiv   +1 more source

Biological view of vaccination described by mathematical modellings: from rubella to dengue vaccines

Mathematical Biosciences and Engineering, 2019
The only rubella vaccine available in North America is the RA27/3 strain (isolated from the kidney of a rubella-infected fetus and attenuated) licensed in 1979, which substituted HPV77/DE5 strain vaccine due to concerns about waning immunity.
Hyun Mo Yang , André Ricardo Ribas Freitas   +1 more
doaj   +1 more source

Recombinant rubella vectors elicit SIV Gag-specific T cell responses with cytotoxic potential in rhesus macaques [PDF]

, 2015
Live-attenuated rubella vaccine strain RA27/3 has been demonstrated to be safe and immunogenic in millions of children. The vaccine strain was used to insert SIV gag sequences and the resulting rubella vectors were tested in rhesus macaques alone and ...
Alicea, Candido, Berkower, Ira, Felber, Barbara K., Hockenbury, Max, Kulkarni, Viraj, Pavlakis, George N., Rosati, Margherita, Sardesai, Niranjan Y., Valentin, Antonio, Virnik, Konstantin   +9 more
core   +1 more source